INMUNE BIO INC (INMB)

US45782T1051 - Common Stock

11.29  +0.45 (+4.15%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
155.00K370.00K180.00K10.00K0.00
Operating Expenses
29.90M26.33M29.33M12.24M7.76M
Research and Development
20.27M17.07M20.54M5.92M3.28M
Selling, General, and Administrative Expenses
9.62M9.26M8.79M6.32M6.02M
Operating Income
-29.74M-25.95M-29.15M-12.23M-7.76M
Interest Income/Expense
-2.28M-2.01M-990.00KN/A80.00K
Other Income/Expense
2.01M670.00K-200.00K130.00KN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-30.01M-27.30M-30.34M-12.10M-7.68M
Net Income
-30.01M-27.30M-30.34M-12.10M-7.68M
 
Per Share Data
EPS Diluted Total Ops
-1.67-1.52-1.88-1.01-0.75
Non GAAP EPS
-1.67-1.52-1.86-1.01-0.89
 
Statistics
Profit Margin
-19360.00%-7378.38%-16855.56%-121000.00%N/A
Operating Profit Margin
-19187.74%-7013.51%-16194.44%-122300.00%N/A

All data in USD

Charts